Using MSCT, an investigative team from Mount Desert Island Hospital in Bar Harbor, ME, confirmed that scurvy was to blame for the death of nearly half of 79 colonists who arrived on Saint Croix Island, ME, in 1604.
Using MSCT, an investigative team from Mount Desert Island Hospital in Bar Harbor, ME, confirmed that scurvy was to blame for the death of nearly half of 79 colonists who arrived on Saint Croix Island, ME, in 1604.
An expedition of French settlers led by Samuel de Champlain settled on the island with the intention of colonizing the North Atlantic coast of North America. The unexpectedly harsh winter that year seemingly contributed to many of the explorers' deaths.
It was only with the advent of multislice CT, however, that researchers could scan the explorers' skeletal remains, which revealed a thick hard palate and an extra layer of bony tissue, a possible consequence of internal bleeding associated with scurvy, said principal investigator Dr. John Benson, director of medical imaging at MDIH.
Benson and colleagues used MSCT to examine remains from seven burial sites, including five femurs, two tibias, two fibulas, two craniums with their mandibles, two mandibles, and one maxilla. Their imaging protocol included 0.5-mm slice thickness, displayed on a commercially available workstation, using isotropic multiplanar reformatting and volume renderings.
MSCT's contributions to anthropological and forensic science are legion, Benson said. CT can make measurements without destroying the artifact. Furthermore, scans provided digital archives for continuous examination and studies without the need to unearth the remains again.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.